Injection/Infusion
ENDOLUCINBETA RADIOPHARMACEUTICAL PRECURSOR, SOLUTION 40GBQ/ML IN 2ML VIAL
Summary
ENDOLUCINBETA RADIOPHARMACEUTICAL PRECURSOR, SOLUTION 40GBQ/ML IN 2ML VIAL — Injection/Infusion containing lutetium (177Lu) chloride. Hong Kong Registration No. HK-66999. Certificate Holder: PE PHARMA LIMITED. Date of Registration: 27 Feb, 2021.
Product NameENDOLUCINBETA RADIOPHARMACEUTICAL PRECURSOR, SOLUTION 40GBQ/ML IN 2ML VIAL
Registration No.HK-66999
Certificate HolderPE PHARMA LIMITED
Holder AddressRM 801-803, 8/F, PARK SUN BLDG, NO. 97-107 WO YI HOP RD, KWAI CHUNG, NEW TERRITORIES
Ingredientslutetium (177Lu) chloride
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration27 Feb, 2021
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。